MedTrace Logo

A Study to Evaluate the Effect of a Medicine on Gastric Functions in Healthy Volunteers.

NCT00308399 · Status: COMPLETED · Phase: PHASE2/PHASE3 · Type: INTERVENTIONAL · Enrollment: 45

Last updated 2011-03-23

No results posted yet for this study

Summary

A 7 day study which involves 2 nutrient drink tests, an ECG, a Scintigraphy scan, and a Sect scan. This study requires the participant to make 4 visits to the GCRC in the Charlton building but no overnight stays.

Conditions

  • Healthy Volunteers

Interventions

DRUG

Itopride

Sponsors & Collaborators

  • Axcan Pharma

    collaborator INDUSTRY

  • Mayo Clinic

    lead OTHER

Principal Investigators

  • Nicholas J. Talley, M.D., Ph.D. · Mayo Clinic

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
45 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2005-11-30
Primary Completion
2007-06-30
Completion
2007-06-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00308399 on ClinicalTrials.gov